CN113457062B - 含四氢大麻酚洗脱液的销毁方法 - Google Patents
含四氢大麻酚洗脱液的销毁方法 Download PDFInfo
- Publication number
- CN113457062B CN113457062B CN202110726257.5A CN202110726257A CN113457062B CN 113457062 B CN113457062 B CN 113457062B CN 202110726257 A CN202110726257 A CN 202110726257A CN 113457062 B CN113457062 B CN 113457062B
- Authority
- CN
- China
- Prior art keywords
- tetrahydrocannabinol
- chlorine dioxide
- thc
- aqueous solution
- destroying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 title claims abstract description 123
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 title claims abstract description 123
- 229960004242 dronabinol Drugs 0.000 title claims abstract description 123
- 238000000034 method Methods 0.000 title claims abstract description 38
- 239000003480 eluent Substances 0.000 title claims abstract description 35
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 claims abstract description 106
- 239000004155 Chlorine dioxide Substances 0.000 claims abstract description 53
- 235000019398 chlorine dioxide Nutrition 0.000 claims abstract description 53
- 239000007864 aqueous solution Substances 0.000 claims abstract description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 42
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 6
- 229910001919 chlorite Inorganic materials 0.000 claims description 3
- 229910052619 chlorite group Inorganic materials 0.000 claims description 3
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000007788 liquid Substances 0.000 description 17
- 238000003756 stirring Methods 0.000 description 14
- 230000006378 damage Effects 0.000 description 12
- 239000007800 oxidant agent Substances 0.000 description 10
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 9
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 9
- 229950011318 cannabidiol Drugs 0.000 description 9
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000001590 oxidative effect Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 5
- 238000009776 industrial production Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229910017604 nitric acid Inorganic materials 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000012286 potassium permanganate Substances 0.000 description 3
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 3
- 229960002218 sodium chlorite Drugs 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241000218236 Cannabis Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- -1 aromatic terpene Chemical class 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- JHWIEAWILPSRMU-UHFFFAOYSA-N 2-methyl-3-pyrimidin-4-ylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=NC=N1 JHWIEAWILPSRMU-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000008697 Cannabis sativa Nutrition 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010048393 Multiple sclerosis relapse Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 230000003400 hallucinatory effect Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- NWAPVVCSZCCZCU-UHFFFAOYSA-L magnesium;dichlorite Chemical compound [Mg+2].[O-]Cl=O.[O-]Cl=O NWAPVVCSZCCZCU-UHFFFAOYSA-L 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- VISKNDGJUCDNMS-UHFFFAOYSA-M potassium;chlorite Chemical compound [K+].[O-]Cl=O VISKNDGJUCDNMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000002341 toxic gas Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/30—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
- A62D3/38—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents by oxidation; by combustion
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2101/00—Harmful chemical substances made harmless, or less harmful, by effecting chemical change
- A62D2101/20—Organic substances
- A62D2101/28—Organic substances containing oxygen, sulfur, selenium or tellurium, i.e. chalcogen
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Business, Economics & Management (AREA)
- Emergency Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110726257.5A CN113457062B (zh) | 2021-06-29 | 2021-06-29 | 含四氢大麻酚洗脱液的销毁方法 |
PCT/CN2022/097527 WO2023273819A1 (zh) | 2021-06-29 | 2022-06-08 | 销毁四氢大麻酚的方法及氧化剂组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110726257.5A CN113457062B (zh) | 2021-06-29 | 2021-06-29 | 含四氢大麻酚洗脱液的销毁方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113457062A CN113457062A (zh) | 2021-10-01 |
CN113457062B true CN113457062B (zh) | 2022-06-28 |
Family
ID=77873663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110726257.5A Active CN113457062B (zh) | 2021-06-29 | 2021-06-29 | 含四氢大麻酚洗脱液的销毁方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113457062B (zh) |
WO (1) | WO2023273819A1 (zh) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102626104B (zh) * | 2012-03-22 | 2014-01-08 | 广东环凯微生物科技有限公司 | 一种稳定性二氧化氯消毒液及其制备方法 |
CN106563685B (zh) * | 2016-10-14 | 2020-03-24 | 汉义生物科技(北京)有限公司 | 一种销毁四氢大麻酚的方法 |
US11696583B2 (en) * | 2018-12-13 | 2023-07-11 | ProKure Solutions, LLC | Systems and methods for use of chlorine dioxide in cultivation and post-harvest applications |
WO2020248077A1 (en) * | 2019-06-12 | 2020-12-17 | Nectar Health Sciences Inc. | Methods for extraction, processing, and purification of a selected family of target compounds from cannabis |
CN110746275A (zh) * | 2019-11-08 | 2020-02-04 | 河南汉麻生物科技有限公司 | 一种利用连续色谱系统分离大麻二酚的方法 |
CN111514513B (zh) * | 2020-05-06 | 2021-06-25 | 中国农业科学院农业资源与农业区划研究所 | 一种毒品无害化处理方法 |
CN112023327A (zh) * | 2020-08-21 | 2020-12-04 | 滇麻生物科技(曲靖)有限公司 | 一种四氢大麻酚的销毁方法 |
-
2021
- 2021-06-29 CN CN202110726257.5A patent/CN113457062B/zh active Active
-
2022
- 2022-06-08 WO PCT/CN2022/097527 patent/WO2023273819A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN113457062A (zh) | 2021-10-01 |
WO2023273819A1 (zh) | 2023-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gao et al. | Enhanced peroxymonosulfate activation via complexed Mn (II): A novel non-radical oxidation mechanism involving manganese intermediates | |
Satoh et al. | Methylene blue dye test for rapid qualitative detection of hydroxyl radicals formed in a Fenton's reaction aqueous solution | |
Rastogi et al. | Effect of inorganic, synthetic and naturally occurring chelating agents on Fe (II) mediated advanced oxidation of chlorophenols | |
Moriwaki et al. | Sonochemical decomposition of perfluorooctane sulfonate and perfluorooctanoic acid | |
Carneiro et al. | The effect of the supporting electrolyte on the electrooxidation of enrofloxacin using a flow cell with a BDD anode: Kinetics and follow-up of oxidation intermediates and antimicrobial activity | |
Lee et al. | UV photolytic mechanism of N-nitrosodimethylamine in water: roles of dissolved oxygen and solution pH | |
Luo et al. | Structure elucidation and toxicity analyses of the degradation products of aflatoxin B1 by aqueous ozone | |
Xiang et al. | New insight in the O2 activation by nano Fe/Cu bimetals: The synergistic role of Cu (0) and Fe (II) | |
Li et al. | A sulfate radical based ferrous–peroxydisulfate oxidative system for indomethacin degradation in aqueous solutions | |
Dong et al. | Promoted oxidation of diclofenac with ferrate (Fe (VI)): Role of ABTS as the electron shuttle | |
Mussa et al. | Pseudo first order kinetics and proposed transformation products pathway for the degradation of diclofenac using graphite–PVC composite as anode. | |
Janeiro et al. | Chrysin and (±)‐taxifolin electrochemical oxidation mechanisms | |
Cravotto et al. | Decontamination of soil containing POPs by the combined action of solid Fenton-like reagents and microwaves | |
Bi et al. | Degradation of oxytetracycline with SO4− under simulated solar light | |
Koltsakidou et al. | Photolysis and photocatalysis of the non-steroidal anti-inflammatory drug Nimesulide under simulated solar irradiation: Kinetic studies, transformation products and toxicity assessment | |
CN106563685B (zh) | 一种销毁四氢大麻酚的方法 | |
Guevara-Almaraz et al. | Potential of multisyringe chromatography for the on-line monitoring of the photocatalytic degradation of antituberculosis drugs in aqueous solution | |
Huguet et al. | Transformation of paracetamol into 1, 4-benzoquinone by a manganese oxide bed filter | |
CN113457062B (zh) | 含四氢大麻酚洗脱液的销毁方法 | |
Graumans et al. | Oxidative degradation of cyclophosphamide using thermal plasma activation and UV/H2O2 treatment in tap water | |
Shi et al. | Chemical oxidation of bis (2-chloroethyl) ether in the Fenton process: Kinetics, pathways and toxicity assessment | |
CN111634991A (zh) | 一种改性炭材料在活化高铁酸盐降解抗生素污染物的应用 | |
Al-Qaim et al. | The fate of prazosin and levonorgestrel after electrochemical degradation process: Monitoring by-products using LC-TOF/MS | |
CN105080027B (zh) | 以纳米零价铁为主要消毒成分的消毒材料及其制备方法 | |
Hidaka et al. | Microwave-assisted dechlorination of polychlorobenzenes by hypophosphite anions in aqueous alkaline media in the presence of Pd-loaded active carbon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231018 Address after: 675099 Chuxiong Small and Medium Enterprise Service Center, east of the south gate of Chufeng Garden, Sunshine Avenue, Lucheng Town, Chuxiong City, Chuxiong Yi Autonomous Prefecture, Yunnan Province Patentee after: Yunnan Suyan Biotechnology Co.,Ltd. Address before: 650200 No. 9-3d, building A8, Kunming International Industrial Hemp Industrial Park, No. 38, Jingjing Road, economic development zone, Kunming area, China (Yunnan) pilot Free Trade Zone, Guandu District, Kunming, Yunnan Province Patentee before: Yunnan dianmei Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |